BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2795739)

  • 1. Human renal cell carcinoma in the six day subrenal capsule assay.
    Weissglas MG; Romijn JC; van Dongen JW; Cappendijk MJ; ten Kate FJ; Kurth KH
    J Urol; 1989 Oct; 142(4):1106-9. PubMed ID: 2795739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fundamental studies on the subrenal capsule assay as chemosensitivity test for nonsolid tumors].
    Sakamoto T; Ogino M; Yamamoto T; Mori H; Okinaga S; Arai K
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 May; 42(5):415-21. PubMed ID: 2197356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A biochemical evaluation of oral squamous cell carcinoma growth by measurement of specific activity of succinate dehydrogenase in the subrenal capsule assay.
    Munakata H; Kayada Y; Kawahara M; Sakamoto T; Yoshiga K; Takada K
    Int J Oral Maxillofac Surg; 1995 Jun; 24(3):216-20. PubMed ID: 7594755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Subrenal capsule assay using nude mice].
    Kikuchi H; Asamura M; Gamoh M; Ohuchi H; Wakui A
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):532-41. PubMed ID: 2321981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Subrenal capsule assay for chemosensitivity test of urinary tract cancers].
    Hasegawa J; Yamanaka Y; Horiuchi K; Akimoto M
    Nihon Hinyokika Gakkai Zasshi; 1989 Jun; 80(6):856-60. PubMed ID: 2796104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Subrenal capsule assay--histological evaluation of chemotherapy responsiveness].
    Nemoto R; Uchida K; Shimazui T; Ishikawa S; Koiso K
    Nihon Hinyokika Gakkai Zasshi; 1987 Apr; 78(4):643-8. PubMed ID: 3669473
    [No Abstract]   [Full Text] [Related]  

  • 7. [Analysis of the chemosensitivity test by human tumor clonogenic assay and subrenal capsule assay].
    Terashima M
    Nihon Geka Gakkai Zasshi; 1987 Nov; 88(11):1554-64. PubMed ID: 3431536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Applicability of the subrenal capsule assay (SRCA) in primary breast carcinoma].
    Gerber B; Richter D; Rohde E; Wilken H; Rudolf K; Kasch R
    Arch Geschwulstforsch; 1989; 59(2):85-91. PubMed ID: 2541670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a high metastatic orthotopic model of human renal cell carcinoma in nude mice: benefits of fragment implantation compared to cell-suspension injection.
    An Z; Jiang P; Wang X; Moossa AR; Hoffman RM
    Clin Exp Metastasis; 1999 May; 17(3):265-70. PubMed ID: 10432012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fundamental study of subrenal capsule assay by measuring specific activity of succinate dehydrogenase].
    Munakata H; Kawahara M; Kayada Y; Sakamoto T; Takada K
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):217-22. PubMed ID: 1371048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-sensitivity testing in patients with human oesophageal squamous cell carcinoma.
    Terashima M; Ikeda K; Maesawa C; Kawamura H; Ishida K; Sato M; Saito K
    Eur J Cancer; 1992; 28A(8-9):1347-50. PubMed ID: 1515248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Subrenal capsule assay for chemosensitivity test of urological malignancy].
    Mitsui H; Shimabukuro T; Yamamoto M; Yamamoto N; Sakatoku J
    Hinyokika Kiyo; 1990 Jul; 36(7):757-63. PubMed ID: 2239572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of chemosensitivity in the 6-day subrenal capsule assay].
    Inoue K
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2423-30. PubMed ID: 3619455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subrenal capsule assay using nude mice as a predictor of the response of the gastric cancer to chemotherapy.
    Yamauchi M; Satta T; Ito A; Kondo K; Akiyama S; Ito K; Watanabe T; Takagi H
    J Surg Oncol; 1991 Jun; 47(2):98-101. PubMed ID: 1905767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitotic index in the subrenal capsule assay as an indicator of the chemosensitivity of ovarian cancer.
    Suonio E; Lipponen P; Mäenpää J; Syrjänen K; Kangas L; Tuomisto L
    Cancer Chemother Pharmacol; 1997; 41(1):15-21. PubMed ID: 9443609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of clinically relevant tumor models from patients with renal cell carcinoma.
    Karam JA; Zhang XY; Tamboli P; Margulis V; Wang H; Abel EJ; Culp SH; Wood CG
    Eur Urol; 2011 Apr; 59(4):619-28. PubMed ID: 21167632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy responsiveness of human tumors as first transplant generation xenografts in the normal mouse: six-day subrenal capsule assay.
    Bogden AE; Cobb WR; Lepage DJ; Haskell PM; Gulkin TA; Ward A; Kelton DE; Esber HJ
    Cancer; 1981 Jul; 48(1):10-20. PubMed ID: 6263448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A four-day subrenal capsule assay for testing the effectiveness of anticancer drugs against human tumors.
    Levi FA; Blum JP; Lemaigre G; Bourut C; Reinberg A; Mathé G
    Cancer Res; 1984 Jun; 44(6):2660-7. PubMed ID: 6722799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic potential of human renal cell carcinoma: experimental model using subrenal capsule implantation in athymic nude mice.
    Grossi FS; Zhao X; Romijn JC; ten Kate FJ; Schröder FH
    Urol Res; 1992; 20(4):303-6. PubMed ID: 1509637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The subrenal capsule assay for chemosensitivity testing of tumors. A review.
    Mäenpää J; Kangas L; Grönroos M
    Zentralbl Gynakol; 1988; 110(16):989-96. PubMed ID: 3055756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.